$16.14
0.915.98%
In chiusura: -
$16.14
0.000.00%
After hour: Oct 3, 9:27 AM EDT
Pharming segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Pharming utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
PHAR | Pharming | -$0.02 | $0.02 | — | — | $74.85M | $84.79M | — | — | 10/23/2025 | |
PHAR | Pharming | -$0.02 | -$0.05 | $0.06 | 220.00% | $74.10M | $75.27M | $93.20M | 23.82% | 07/31/2025 | |
PHAR | Pharming | -$0.19 | -$0.03 | -$0.22 | -633.33% | $55.59M | $58.91M | $79.10M | 34.27% | 05/08/2025 | |
PHAR | Pharming | $0.04 | $0.01 | $0.05 | 400.00% | $81.20M | $76.67M | $92.70M | 20.91% | 03/13/2025 | |
PHAR | Pharming | $0.01 | $0.01 | -$0.02 | -300.00% | $66.70M | $76.93M | $74.85M | -2.71% | 10/24/2024 | |
PHAR | Pharming | $0.00 | — | -$0.02 | — | $54.90M | — | $74.10M | — | 08/01/2024 | |
PHAR | Pharming | -$0.02 | — | -$0.19 | — | $42.54M | — | $55.59M | — | 05/08/2024 | |
PHAR | Pharming | -$0.02 | — | -$0.04 | — | $54.62M | — | $81.20M | — | 03/14/2024 | |
PHAR | Pharming | $0.01 | — | $0.05 | — | $54.20M | — | $66.70M | — | 10/26/2023 | |
PHAR | Pharming | $0.02 | — | $0.00 | — | $50.15M | — | $54.90M | — | 08/03/2023 | |
PHAR | Pharming | $0.01 | — | -$0.02 | — | $46.62M | — | $42.54M | — | 05/11/2023 | |
PHAR | Pharming | $0.01 | — | -$0.02 | — | $52.77M | — | $54.62M | — | 03/16/2023 | |
PHAR | Pharming | -$0.00 | — | $0.01 | — | $52.86M | — | $54.20M | — | 10/27/2022 | |
PHAR | Pharming | $0.01 | — | $0.02 | — | $49.67M | — | $50.15M | — | 08/04/2022 | |
PHAR | Pharming | $0.02 | — | $0.01 | — | $43.56M | — | $46.62M | — | 05/12/2022 | |
PHAR | Pharming | $0.02 | — | $0.01 | — | $60.30M | — | $52.77M | — | 03/17/2022 | |
PHAR | Pharming | $0.01 | — | -$0.00 | — | $36.89M | — | $52.86M | — | 10/28/2021 | |
PHAR | Pharming | — | — | $0.01 | — | — | — | $49.67M | — | 08/05/2021 | |
PHAR | Pharming | — | — | $0.02 | — | — | — | $43.56M | — | 05/13/2021 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-07-31 | $0.06 | $-0.05 | 220.0 % |
Q1 | 2025-05-08 | $-0.22 | $-0.03 | -633.3 % |
Q4 | 2025-03-13 | $0.05 | $0.01 | 400.0 % |
Q3 | 2024-10-24 | $-0.02 | $0.01 | -300.0 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-07-31 | $93.20M | $75.27M | 23.8 % |
Q1 | 2025-05-08 | $79.10M | $58.91M | 34.3 % |
Q4 | 2025-03-13 | $92.70M | $76.67M | 20.9 % |
Q3 | 2024-10-24 | $74.85M | $76.93M | -2.71 % |
Si prevede che Pharming (PHAR) fornisca risultati il ottobre 23, 2025. Gli ultimi risultati sono stati pubblicati il luglio 31, 2025 per il Q2.
L'EPS effettivo era $0.06, che superato la stima di $-0.05.
Le entrate effettive sono state $93.2M, che superato la stima di $75.3M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.